BioSyent Inc. (TSXV: RX)

BioSyent Revenue

BioSyent had revenue of 9.56M CAD in the quarter ending September 30, 2024, with 7.72% growth. This brings the company's revenue in the last twelve months to 34.51M, up 12.12% year-over-year. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.

• Revenue (ttm): 34.51M
• Revenue Growth: +12.12%
• P/S Ratio: 3.82
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 131.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	31.59M	3.67M	13.12%
Dec 31, 2022	27.93M	-693.03K	-2.42%
Dec 31, 2021	28.62M	6.29M	28.15%
Dec 31, 2020	22.33M	907.84K	4.24%
Dec 31, 2019	21.42M	-102.70K	-0.48%